Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Karyopharm Therapeutics Inc. (KPTI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,589 shares @ $1.27, valued at $4.6k
08/08/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,722 shares @ $1.72, valued at $6.4k
08/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 SC 13G/A STATE STREET CORP reports a 1.9% stake in EXIT FILING KARYOPHARM THERAPEUTICS INC
07/06/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,538 shares @ $1.72, valued at $6.1k
06/12/2023 4 Cheng Sohanya Roshan (EVP & Chief Commercial Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 1,839 shares @ $2.35, valued at $4.3k
06/07/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,536 shares @ $2.2404, valued at $7.9k
05/25/2023 4 Schor Chen (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 4 PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 4 Oliger Christy J. (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 4 Mirza Mansoor Raza (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 4 Honig Peter (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 4 BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 4 Greene Barry E (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 34,000 options to buy @ $2.5, valued at $85k
05/25/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/08/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,805 shares @ $3.3516, valued at $12.8k
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,497 shares @ $3.97, valued at $13.9k
03/31/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549"
03/07/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 3,506 shares @ $3.16, valued at $11.1k
03/02/2023 4 Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 100,000 shares @ $0
03/02/2023 4 Poulton Stuart (EVP, Chief Development Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 95,000 shares @ $0
03/02/2023 4 Mitchener Stephen (SVP, Chief Business Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 60,000 shares @ $0
Sold 6,357 shares @ $3.0292, valued at $19.3k
03/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2023 4 Cheng Sohanya Roshan (EVP & Chief Commercial Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 100,000 shares @ $0
Sold 11,239 shares @ $3.0292, valued at $34k
03/02/2023 4 Mason Michael (EVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 95,000 shares @ $0
Sold 11,205 shares @ $3.0292, valued at $33.9k
03/02/2023 4 Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 252,000 shares @ $0
Sold 33,033 shares @ $3.0292, valued at $100.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy